Holen Sie sich die Stockscreener-App
23.88
2.01%
0.47
Handel nachbörslich:
24.36
0.48
+2.01%
Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten
Technical Reactions to GLSI Trends in Macro Strategies - Stock Traders Daily
Greenwich LifeSciences, Inc. Q1 2026 Quarterly Report: Financials, Risk Factors, and Disclosure Highlights - Minichart
Trading the Move, Not the Narrative: (GLSI) Edition - Stock Traders Daily
Greenwich LifeSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Greenwich LifeSciences (GLSI) loss widens as ATM equity raises fund trials - Stock Titan
What’s Driving GLSI Stock Today? - Stocktwits
These 10 small-cap U.S. healthcare companies carry the market's most expensive valuations - Seeking Alpha
Greenwich LifeSciences, Inc. 2024 Annual Report: Breast Cancer Immunotherapy Pipeline, Clinical Trials, and Regulatory Risks - minichart.com.sg
GREENWICH LIFESCIENCES ($GLSI) Releases Q4 2025 Earnings - Quiver Quantitative
Greenwich LifeSciences FY 2025: Net loss $19.4M, No revenue — 10-K Summary - TradingView
Greenwich LifeSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Greenwich LifeSciences delays 10-K filing, cites audit coordination By Investing.com - Investing.com Nigeria
Greenwich LifeSciences presents immune response data at ASCO - Investing.com
Greenwich LifeSciences presents immune response data at ASCO By Investing.com - Investing.com South Africa
Breast cancer trial: GLSI-100 shots spark injection-site reactions over time - Stock Titan
GLSI Stock Climbs After Removing A Key Overhang – Retail Turns Focus To High-Stakes Breast Cancer Trial - TradingView
Greenwich LifeSciences Says Audit of 2025 Form 10-K Filing in Final Stages of Approval - Moomoo
Greenwich Lifesciences Provides Update Regarding Form 10-K Filing - TradingView
Greenwich LifeSciences updates on Form 10-K filing progress - Traders Union
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing - The Manila Times
Greenwich LifeSciences, Inc. Provides Update on 2025 Form 10-K Filing and Phase III Clinical Trial Progress - Quiver Quantitative
Greenwich LifeSciences delays 10-K filing, cites audit coordination - Investing.com
Breast cancer trial firm details audit delay, $10.5M cash - Stock Titan
Auddia’s Discovr Radio Forms AI-Driven Partnership With Beatcave to Expand Independent Artist Discovery Across Canada - Weekly Voice
Greenwich LifeSciences, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Greenwich LifeSciences (GLSI) Drops Nearly 10%: Key Support and Resistance Levels in FocusInsider Selling Alerts - The Legal Advocate
GLSI Q3 2025 Earnings: Narrower-than-Expected Loss as Biotech Advances Clinical PipelineLow Growth Earnings - newsline.com
Greenwich LifeSciences (GLSI) Slips Marginally as Stock Holds Above Key SupportIchimoku Kumo Twist - The Legal Advocate
Greenwich LifeSciences Inc. (GLSI) Q3 2025 Earnings: Narrowed Loss Highlights Progress in Immunotherapy DevelopmentQuarterly Earnings - newsline.com
Greenwich LifeSciences (GLSI) Surges 7% as Biotech Momentum BuildsHigh Dividend Factor - newsline.com
GLSI Technical Analysis | Trend, Signals & Chart Patterns | GREENWICH LIFESCIENCES INC (NASDAQ:GLSI) - ChartMill
Greenwich LifeSciences Inc. (GLSI) Edges Higher as Shares Approach Key ResistanceDouble EMA - The Legal Advocate
(GLSI) Volatility Zones as Tactical Triggers - Stock Traders Daily
Greenwich LifeSciences receives Nasdaq notice regarding late Form 10-Q filing - MSN
Greenwich LifeSciences receives Nasdaq noncompliance notice By Investing.com - Investing.com Nigeria
Greenwich LifeSciences: Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing - Moomoo
Greenwich LifeSciences receives Nasdaq noncompliance notice - Investing.com
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Weekly Voice
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing - Weekly Voice
Greenwich Lifesciences Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Price-Driven Insight from (GLSI) for Rule-Based Strategy - Stock Traders Daily
Greenwich LifeSciences (NASDAQ:GLSI) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Greenwich LifeSciences (GLSI) shares fall 3% despite tiny EPS beat; investors demand clinical progress updates. - newser.com
(GLSI) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Greenwich LifeSciences delays annual report filing - Investing.com UK
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):